Nadal, Aquilla Loraine A.
HRN: 24-78-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/01/2025
05/07/2025
IVTT
105mg
Q6
T/C Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes